Company Elite Pharmaceuticals, Inc.

Equities

ELTP

US28659T2006

Pharmaceuticals

Market Closed - OTC Markets 03:58:34 2024-04-19 pm EDT 5-day change 1st Jan Change
0.13 USD -2.62% Intraday chart for Elite Pharmaceuticals, Inc. -7.14% -7.14%

Business Summary

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. The Company specializes in developing and manufacturing oral, controlled-release drug products. It owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Phendimetrazine Tartrate 35mg tablets, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Trimipramine Maleate Immediate Release 25mg, 50mg and 100mg capsules, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.

Number of employees: 53

Sales per Business

USD in Million2022Weight2023Weight Delta
Abbreviated New Drug Applications
100.0 %
32 100.0 % 34 100.0 % +5.87%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
32 100.0 % 34 100.0 % +5.87%

Managers

Managers TitleAgeSince
Chief Executive Officer 63 13-07-31
Director of Finance/CFO 59 09-06-30
President 69 02-10-31
Chief Operating Officer 61 13-08-11
Investor Relations Contact - 02-12-31
Corporate Officer/Principal 56 22-09-05
General Counsel - 14-10-19

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 09-10-22
Director/Board Member 93 05-03-31
Director/Board Member 76 16-04-27
Chief Executive Officer 63 13-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,017,881,199 791,526,006 ( 77.76 %) 100,000 ( 0.009824 %) 77.76 %

Shareholders

NameEquities%Valuation
221,572,397 21.77 % 34 M $
Barry Dash
0.3179 %
3,235,555 0.3179 % 498 275 $
3,187,020 0.3131 % 490 801 $
2,049,436 0.2014 % 315 613 $
1,133,932 0.1114 % 174 626 $
Choice Investment Management LLC
0.000305 %
3,100 0.000305 % 477 $

Company contact information

Elite Pharmaceuticals, Inc.

165 Ludlow Avenue

07647, Northvale

+

http://www.elitepharma.com
address Elite Pharmaceuticals, Inc.(ELTP)
  1. Stock Market
  2. Equities
  3. ELTP Stock
  4. Company Elite Pharmaceuticals, Inc.